-
4 weeks ago | 
healio.com | Isabella Hornick |Kristen Dowd |Jeffrey A Sparks
Key takeaways: Patients with arthritis and COPD vs. without COPD had a significantly heightened adjusted risk for all-cause mortality. This was also the case for CVD and chronic lower respiratory disease mortality. The risk for all-cause and cardiovascular disease mortality was heightened when adults had arthritis plus comorbid COPD, according to data published inChronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.
-
Jan 31, 2025 | 
healio.com | Rob Volansky |Shenaz Bagha |Jeffrey A Sparks |Kevin L. Winthrop
Inconsistent messaging and evolving recommendations surrounding COVID-19 vaccination protocols may have contributed to both hesitancy and fatigue regarding vaccines among patients, according to experts.
-
Jan 17, 2025 | 
acrjournals.onlinelibrary.wiley.com | Leonard Calabrese |Michael Putman |Jeffrey A Sparks |Zachary S. Wallace
Corresponding Author Leonard H Calabrese DO Cleveland Clinic, Cleveland Clinic Lerner College of Medicine Corresponding author: Leonard H. Calabrese, D.O., Professor of Medicine, Cleveland Clinic Lerner College of Medicine, RJ Fasenmyer Chair of Clinical Immunology, Vice Chairman, Department of Rheumatic and Immunologic Diseases, 9500 Euclid Avenue, Desk A50, Cleveland, Ohio 44195, Phone: (216) 444-5258, Fax: (216) 445-7569.
-
Jan 8, 2025 | 
healio.com | Richard Gawel |Kristen Dowd |Jeffrey A Sparks |Richard P. Ramonell
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The association between asthma and rheumatoid arthritis remains unknown. Eight of nine patients with asthma and rheumatoid arthritis had severe asthma. Two-thirds of patients had evidence of atopy.
-
Dec 3, 2024 | 
healio.com | Jeffrey A Sparks |Marley Ghizzone
-
Dec 3, 2024 | 
healio.com | Jeffrey A Sparks |Marley Ghizzone |Shenaz Bagha
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. WASHINGTON — Healio spoke with Jeffrey A.
-
Dec 2, 2024 | 
healio.com | Jeffrey A Sparks |Marley Ghizzone
-
Dec 2, 2024 | 
healio.com | Jeffrey A Sparks |Marley Ghizzone |Shenaz Bagha
You've successfully added Rheumatoid Arthritis to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. WASHINGTON — In this video, Jeffrey A. Sparks, MD, MMSc, discusses two translational studies focused on human tissue for the treatment of rheumatoid arthritis.
-
Nov 26, 2024 | 
rheumnow.com | Jeffrey A Sparks
Over the past 5 years, there has been growing interest in RA-ILD due to its relative prevalence and severity. This seems to be one of the few RA outcomes not improving much, even with the advent of expanded treatment options. There is also a shocking lack of trial data. Despite this being the most common systemic rheumatic diseases, only three trials have enrolled a total of 217 patients to treat ILD.
-
Sep 26, 2024 | 
hcplive.com | Gordon Lam |Leonard Calabrese |Grace Wright |Jeffrey A Sparks |Catherine Bakewell
September 26, 2024By Panelists discuss how their approaches to treating patients with rheumatoid arthritis focus on personalized strategies that prioritize achieving remission while carefully monitoring safety and efficacy outcomes. Video content above is prompted by the following:Can each of you provide closing remarks on how you treat your own patients to achieve remission? Related Content Related Content
